SCHEMBL6028792

SCHEMBL6028792

NC(=O)c1cccc2cc(-c3cccc(Cl)c3)[nH]c12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 2/20 0.55
CHUK O15111 1/20 0.55
DHODH Q02127 1/20 0.55
PARP1 P09874 4/20 0.54
JAK2 O60674 1/20 0.47
FFAR1 O14842 1/20 0.45
PPARG P37231 1/20 0.45
DHFR P00374 1/20 0.45
PDPK1 O15530 1/20 0.44
HDAC11 Q96DB2 1/20 0.43
PARP2 Q9UGN5 1/20 0.43
PARP3 Q9Y6F1 1/20 0.43
BTK Q06187 2/20 0.42
PLK4 O00444 1/20 0.42
CHEK1 O14757 1/20 0.42
AURKA O14965 1/20 0.42
DAPK3 O43293 1/20 0.42
MAP4K4 O95819 1/20 0.42
CSF1R P07333 1/20 0.42
RET P07949 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6028892 0.87 DHODH (0.59) IKBKBCHUKDHODHPARP1PDPK1
SCHEMBL6028632 0.84 DHODH (0.56) IKBKBCHUKDHODHPARP1JAK2
SCHEMBL6029671 0.84 DHODH (0.68) IKBKBCHUKDHODHPARP1PDPK1
SCHEMBL6028768 0.83 DHODH (0.55) DHODHPARP1PDPK1HDAC11BTK
SCHEMBL6029180 0.83 DHODH (0.55) DHODHPARP1PDPK1HDAC11BTK
SCHEMBL6029606 0.83 DHODH (0.78) IKBKBCHUKDHODHPARP1PDPK1
SCHEMBL6028084 0.82 DHODH (0.59) IKBKBCHUKDHODHPARP1PDPK1
SCHEMBL6028814 0.80 PARP1 (0.57) IKBKBDHODHPARP1JAK2PDPK1
SCHEMBL6029836 0.80 DHODH (0.51) IKBKBCHUKDHODHPARP1PDPK1
SCHEMBL6029417 0.80 HDAC11 (0.58) DHODHPARP1JAK2PDPK1HDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7087637-B2 Substituted indoles which are PARP inhibitors BASF AG (DE) 2006-08-08 US disclosed
US-20040067949-A1 Substituted indoles which are parp inhibitors ABBVIE DEUTSCHLAND GMBH & CO KG (DE) 2004-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067949-A1 Substituted indoles which are parp inhibitors PARP1, PARP2, PARP12 IKBKB 480/4885CHUK 222/4885DHODH 674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.